Menu Search
Equities

Spago Nanomedical AB (publ)

SPAGO:STO

Spago Nanomedical AB (publ)

Actions
  • Price (SEK)0.232
  • Today's Change0.002 / 0.87%
  • Shares traded10.86k
  • 1 Year change-35.91%
  • Beta2.0224
Data delayed at least 15 minutes, as of Sep 20 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Spago Nanomedical AB (publ) had net income fall 7.72% from a loss of 39.20m to a larger loss of 42.22m despite a 14.14% increase in revenues from 1.05m to 1.20m.
Gross margin-97.96%
Net profit margin-1,980.40%
Operating margin-2,033.08%
Return on assets-76.46%
Return on equity-87.09%
Return on investment-86.74%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at Spago Nanomedical AB (publ) fell by 16.88m. Cash Flow from Financing totalled 28.53m or 2,371.57% of revenues. In addition the company used 44.91m for operations while cash used for investing totalled 506.00k.
Cash flow per share-0.2073
Price/Cash flow per share--
Book value per share0.1436
Tangible book value per share0.1436
More ▼

Balance sheet in SEKView more

Spago Nanomedical AB (publ) appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio7.91
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.